ClinicalTrials.Veeva

Menu

Probiotics for Prevention of Antibiotic Associated Diarrhea and Clostridium Difficile Associated Disease

Rutgers The State University of New Jersey logo

Rutgers The State University of New Jersey

Status

Terminated

Conditions

Diarrhea

Treatments

Dietary Supplement: Probiotics

Study type

Interventional

Funder types

Other

Identifiers

NCT02076438
Pro2012002450
Grant# PC 14-13 (Other Identifier)

Details and patient eligibility

About

The study will evaluate if administration of probiotic Culturelle (Lactobacillus Rhamnosus GG) along with antibiotics can help decrease the occurrence of diarrhea caused by antibiotics as well as Clostridium difficile Diarrhea.

Full description

Inpatient adult males and females who are at least 18 years of age or older, undergoing treatment with antibiotics irrespective of indication and the type of antibiotics. The setting is an academic hospital.The patients are screened and potentially recruited upon initiation of antibiotic treatment regardless of indication for antibiotic prescription. The participants are patients being admitted to any inpatient units of the hospital for treatment with antibiotics. Exclusion criteria is:

  • Diarrhea on admission or within the preceding week
  • Reported recurrent diarrhea
  • Bowel pathology that could result in diarrhea (including preexisting Inflammatory Bowel disease{IBD}, all forms for colitis or any other condition resulting in preexisting diarrhea)
  • Intake of high risk antibiotics (clindamycin, cephalosporins, aminopenicillins→ well known to cause CDAD) and or more than two courses of other antibiotics in the past four weeks to exclude pre-existing diarrhea associated with antibiotic use
  • Immunosuppression (Chronic steroid use, Active chemotherapy, Active radiotherapy, HIV or any other disorder resulting in a compromise in participants immune status)
  • Bowel surgery causing liquid stools
  • Regular probiotic intake before admission
  • Lactose intolerance or intolerance to dairy products.

Enrollment

110 patients

Sex

All

Ages

18 to 89 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Inpatient adult males and females who are at least 18-89 years of age, undergoing treatment with antibiotics irrespective of indication and the type of antibiotics.

Exclusion criteria

  • Diarrhea on admission or within the preceding week
  • Reported recurrent diarrhea
  • Bowel pathology that could result in diarrhea (including preexisting Inflammatory Bowel disease{IBD}, all forms for colitis or any other condition resulting in preexisting diarrhea)
  • Intake of high risk antibiotics (clindamycin, cephalosporins, aminopenicillins→ well known to cause CDAD) and or more than two courses of other antibiotics in the past four weeks to exclude pre-existing diarrhea associated with antibiotic use
  • Immunosuppression (Chronic steroid use, Active chemotherapy, Active radiotherapy, HIV or any other disorder resulting in a compromise in participants immune status)
  • Bowel surgery causing liquid stools
  • Regular probiotic intake before admission
  • Lactose intolerance or intolerance to dairy products

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

110 participants in 2 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
Placebo capsules
Treatment:
Dietary Supplement: Probiotics
Probiotics
Experimental group
Description:
Lactobacillus Rhamnosus GG 10 billion cfu BID
Treatment:
Dietary Supplement: Probiotics

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems